SLMAP3 isoform modulates cardiac gene expression and function

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Membrane Protein Research

Background:

• Sarcolemmal membrane associated proteins (SLMAPs) are tail-anchored membrane proteins involved in cell growth, protein trafficking, and ion channel regulation.
• Mutations in human SLMAPs are linked to Brugada syndrome, potentially due to impaired sodium channel (Nav1.5) trafficking, affecting cardiac electrical activity.
• Three SLMAP isoforms (SLMAP1, SLMAP2, SLMAP3) are found in the myocardium, but their specific functions are not fully understood.

Purpose of the Study:

• To investigate the role of the SLMAP3 isoform in cardiac function and ion transport.
• To determine the impact of cardiac-specific SLMAP3 overexpression on heart physiology and molecular mechanisms.

Main Methods:

• Generation of transgenic (Tg) mice with cardiac-specific SLMAP3 expression.
• Assessment of cardiac function using fractional shortening and cardiac output measurements.
• Electrocardiogram (ECG) analysis to evaluate cardiac electrical activity.
• Western blot and qRT-PCR to quantify protein and transcript levels of key ion transporters, including Nav1.5 and SERCA2a/PLN.

Main Results:

• Tg mice exhibited a significant decrease in fractional shortening (20%) and cardiac output (11%) by 5 weeks of age.
• ECG revealed a prolonged PR interval (14%) and reduced R amplitude (43%) without cardiac remodeling.
• Protein levels of Nav1.5 decreased by 55%, with a 45% drop in transcript levels. Sarcoplasmic reticulum calcium transport proteins (SERCA2a/PLN) also showed reduced expression.

Conclusions:

• SLMAP3 plays a critical role in the selective regulation of cardiac ion transport proteins, impacting gene expression.
• Cardiac-specific overexpression of SLMAP3 leads to impaired cardiac function and altered ion channel expression.
• SLMAP3 represents a potential therapeutic target for cardiovascular diseases involving ion transport dysfunction.